Despite availability of vaccines, more than 2000 people die every day in the US alone due to COVID-19 and approximately 133,000 new cases are reported daily.¹ Currently, more than 182 million Americans, or 54%, are considered fully vaccinated against SARS-CoV-2, and approximately 64% of the population has received at least one vaccine dose. However, reports indicate that vaccine efficacy reduces with time and booster doses are now recommended despite a lack of unity from the FDA and CDC experts in accepting this step. Moreover, new variants of the coronavirus further complicate the picture, and “breakthrough infections” in the fully vaccinated are on the rise. This situation calls for the revision of current approaches and incorporation of innovative health strategies that are effective, economic, and accepted by the majority of people worldwide.